Edward Kanfer

3.0k citations

55 papers · 1.8k indexed · h-index 26

Hematology top 0.5%
- Hematopoietic Stem Cell Transplantation 22
- Multiple Myeloma Research and Treatments 10
- Chronic Myeloid Leukemia Treatments 9
- Acute Myeloid Leukemia Research 7
Genetics top 2%
- Chronic Lymphocytic Leukemia Research 10
Immunology top 10%
Oncology top 5%
- Polyomavirus and related diseases 5
Transplantation top 10%
Pathology and Forensic Medicine
- Lymphoma Diagnosis and Treatment 8
Public Health, Environmental and Occupational Health
- Acute Lymphoblastic Leukemia research 6

Co-authors: Jane F. Apperley Richard Szydlo Eduardo Olavarría John M. Goldman Amin Rahemtulla D Samson Francesco Dazzi Chrissy Giles
Cited by: Hematology Genetics Immunology
Journals: Blood (11 papers)Bone Marrow Transplantation (9 papers)British Journal of Haematology (4 papers)
Partner nations: United Kingdom Italy France

In The Last Decade

Edward Kanfer

54 papers receiving 1.8k citations

Peers

Countries citing papers authored by Edward Kanfer

Since Specialization

Citations

This map shows the geographic impact of Edward Kanfer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Edward Kanfer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Edward Kanfer more than expected).

Fields of papers citing papers by Edward Kanfer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Edward Kanfer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Edward Kanfer. The network helps show where Edward Kanfer may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Edward Kanfer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Edward Kanfer Line = papers co-authored together Edward Kanfer links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	High-dose chemotherapy with autologous stem cell transplants in adult primary non-seminoma mediastinal germ-cell tumors. A report from the Cellular Therapy and Immunobiology working party of the EBMT ESMO Open ·Simona Secondino,Manuela Badoglio,Gianantonio Rosti,Myriam Labopin,Matthieu Delaye,Carsten Bokemeyer,Christoph Seidel,Edward Kanfer,Elisabetta Metafuni,Jürgen Finke,周玉娟,Christos Kosmas,Florent Malard,Alessia Pagani,Jürgen Kuball,Ulrike Koehl,Annalisa Ruggeri,Ugo De Giorgi,Paolo Pedrazzoli	2024	2
2	Long term outcomes of nonmyeloablative allogeneic stem cell transplantation with TSEB TLI and ATG for Mycosis Fungoides and Sezary Syndrome Bone Marrow Transplantation ·Stephen Morris,P. Hanisko,Mochamad Mardino,Sean Whittaker,Fiona Child,Siwalai Srisatriyanon,Matsumoto Naohiko,Richard Szydlo,Stephen Mangar,Eduardo Olavarría,Gosta Carl Henrik Ehrensvard,黄海鹏,Edward Kanfer	2024	3
3	Fecal Microbiota Transplant Mitigates Adverse Outcomes Seen in Patients Colonized With Multidrug-Resistant Organisms Undergoing Allogeneic Hematopoietic Cell Transplantation Frontiers in Cellular and Infection Microbiology ·Andrew J. Innes,Benjamin H. Mullish,Rohma Ghani,Richard Szydlo,Jane F. Apperley,Eduardo Olavarría,Mochamad Mardino,Edward Kanfer,Dragana Milojković,Julie A. K. McDonald,Eimear Brannigan,Mark Thursz,Horace R. Williams,Frances Davies,Julian R. Marchesi,Jiří Pavlů	2021	23
4	T-cell prolymphocytic leukaemia in a patient with chronic myeloid leukaemia receiving nilotinib: first documented report Journal of Clinical Pathology ·Brian Hanley,Huimin Jiang,Zhiyu Zoey Chen,Smita Daware,F. Zetzsche,ศุภชัย วรพจน์พิศุทธิ์,Simone Claudiani,Dragana Milojković,Edward Kanfer,Jane F. Apperley,Kikkeri N. Naresh	2019	0
5	The results of treatment with high-dose chemotherapy and peripheral blood stem cell support for gestational trophoblastic neoplasia European Journal of Cancer ·Wuri Handayani Suwandi,Christianne Lok,D Short,Kamaljit Singh,Rosemary A. Fisher,Barry W. Hancock,John Tidy,Naveed Sarwar,Edward Kanfer,Matthew Winter,Philip Savage,Michael J. Seckl	2019	33
6	Impact of route and adequacy of nutritional intake on outcomes of allogeneic haematopoietic cell transplantation for haematologic malignancies Clinical Nutrition ·S. Ananda Kumaran,Richard Szydlo,Mary Hickson,D. I. Kamenev,Andrew J. Innes,Ian H Gabriel,Mochamad Mardino,Edward Kanfer,Donald Macdonald,Dragana Milojković,Amin Rahemtulla,Aristeidis Chaidos,Anastasios Karadimitris,Eduardo Olavarría,Jane F. Apperley,Jiří Pavlů	2018	40
7	Salvage high-dose chemotherapy in female patients with relapsed/refractory germ-cell tumors: a retrospective analysis of the European Group for Blood and Marrow Transplantation (EBMT) Annals of Oncology ·Ugo De Giorgi,Sandrine Richard,Manuela Badoglio,Edward Kanfer,S.T. Siti Nandiroh,Emmanuelle Nicolas‐Virelizier,Kim Vettenranta,Bruno Lioure,Sonja Martin,Peter Dreger,Екатерина Михальчи,Kirsty Thomson,Emanuela Scarpi,Giovanni Rosti,Frédèric Selle,Giorgia Mangili,Francesco Lanza,Marco Bregni	2017	14
8	Autologous hematopoietic stem cell transplantation for intravascular large B-cell lymphoma: the European Society for Blood and Marrow Transplantation experience Bone Marrow Transplantation ·Julia Meißner,Hervé Finel,Sascha Dietrich,Ariane Boumendil,Edward Kanfer,Natalʹja Anatolʹevna Borisovskaja,Manuel Abecasis,Jan J. Cornelissen,Jérémy Delage,Jürgen Finke,U Hess,Heinz Ludwig,Mohamad Mohty,Thomas Pabst,Pietro Pioltelli,Stephen Robinson,Panagiotis Samaras,Silvia Montoto,Peter Dreger	2016	23
9	Graft invariant natural killer T-cell dose predicts risk of acute graft-versus-host disease in allogeneic hematopoietic stem cell transplantation Blood ·Aristeidis Chaidos,Scott D. Patterson,Richard Szydlo,Mohammed S. Chaudhry,Francesco Dazzi,Edward Kanfer,Donald M. McDonald,David Marin,Dragana Milojković,Jiří Pavlů,John Davis,Amin Rahemtulla,Katy Rezvani,John M. Goldman,Irene Roberts,Jane F. Apperley,Anastasios Karadimitris	2012	120
10	LACE‐conditioned autologous stem cell transplantation for relapsed or refractory diffuse large B‐cell lymphoma: treatment outcome and risk factor analysis from a single centre Hematological Oncology ·Jiří Pavlů,Holger W. Auner,Sarah Ellis,Richard Szydlo,Chrissy Giles,P. Schell,Amin Rahemtulla,Jane F. Apperley,Kikkeri N. Naresh,Donald Macdonald,Edward Kanfer	2010	7
11	LACE-conditioned autologous stem cell transplantation for relapsed or refractory Hodgkin's lymphoma: treatment outcome and risk factor analysis in 67 patients from a single centre Bone Marrow Transplantation ·Jolanta B. Perz,Chrissy Giles,Richard Szydlo,Derville O’Shea,Jaime Sanz,Aristeidis Chaidos,Simon D. Wagner,John Davis,S. Saied,David Marín,Jane F. Apperley,Eduardo Olavarría,Amin Rahemtulla,Irvin A. Lampert,Kikkeri N. Naresh,D Samson,D. Macdonald,Edward Kanfer	2006	14
12	Predictive factors for survival in myeloma patients who undergo autologous stem cell transplantation: a single-centre experience in 211 patients Bone Marrow Transplantation ·Derville O’Shea,Chrissy Giles,Evangelos Terpos,Jolanta B. Perz,Marianna Politou,Bernhard Kuttin,Kikkeri N. Naresh,Irvin A. Lampert,D Samson,Santosh Narat,Edward Kanfer,Eduardo Olavarría,Jane F. Apperley,Amin Rahemtulla	2006	89
13	High-dose chemotherapy and peripheral blood stem cell support in refractory gestational trophoblastic neoplasia British Journal of Cancer ·Andrew Lawrence,Michael J. Seckl,L. Alexandrova,Linda Evans,Paul Lorigan,S Pors Nielsen,Edward Kanfer,E.S. Newlands,Barry W. Hancock	2005	37
14	High dose chemotherapy and autologous stem cell transplantation as adjuvant therapy for primary breast cancer patients with four or more lymph nodes involved: long-term results of an international randomised trial Annals of Oncology ·R. Charles Coombes,Anthony Howell,Marie A. Emson,Clare Peckitt,C. Gallagher,Carmelo Bengala,A. Trés,R. Joel Welch,P.A. Lawton,R.D. Rubens,E. Woods,Joanne Haviland,David M. Vigushin,Edward Kanfer,Judith M. Bliss	2005	35
15	Paclitaxel-containing high-dose chemotherapy for relapsed or refractory testicular germ cell tumours British Journal of Cancer ·Iain A. McNeish,Edward Kanfer,L. Alexandrova,Chrissy Giles,S.J. Harland,Yurina Noda,Gordon Rustin,E.S. Newlands,Michael J. Seckl	2004	28
16	Survival of patients with chronic-phase chronic myeloid leukaemia on imatinib after failure on interferon alfa The Lancet ·David Marín,Sarah Marktel,Richard Szydlo,John P. Klein,Marco Bua,Nicola Foot,Eduardo Olavarría,Antonio Reina Sanchez,Edward Kanfer,John M. Goldman,Jane F. Apperley	2003	27
17	Cytomegalovirus seropositivity adversely influences outcome after T‐depleted unrelated donor transplant in patients with chronic myeloid leukaemia: the case for tailored graft‐versus‐host disease prophylaxis British Journal of Haematology ·Charles Craddock,Richard Szydlo,Francesco Dazzi,Eduardo Olavarría,Kate Cwynarski,Agnes S. M. Yong,Paul Brookes,Josu de la Fuente,Edward Kanfer,Jane F. Apperley,J M Goldman	2001	91
18	CD34⁺‐selected peripheral blood progenitor cell transplantation in patients with multiple myeloma: tumour cell contamination and outcome British Journal of Haematology ·Tapas K. Das Gupta,A Bybee,Fiona J. Cooke,Chrissy Giles,John Davis,Christine McDonald,S Armitage,Emma Vestergaard,M. P. A. Lyttelton,Edward Kanfer,Jane F. Apperley,Diana Samson	1999	30
19	Persistence of multilineage host haemopoiesis following allogeneic bone marrow transplantation British Journal of Haematology ·Cathy M. Price,Susan Colman,Edward Kanfer	1995	5
20	Thalidomide for the therapy of graft-versus-host disease following allogeneic bone marrow transplantation Biomedicine & Pharmacotherapy ·D. McCarthy,Edward Kanfer,A. John Barrett	1989	23

About Edward Kanfer

Edward Kanfer is a scholar working on Hematology, Genetics, Transplantation, Oncology and Pathology and Forensic Medicine, having authored 55 papers that have together received 1.8k indexed citations. Recurring topics across this work include Hematopoietic Stem Cell Transplantation (22 papers), Chronic Lymphocytic Leukemia Research (10 papers), Multiple Myeloma Research and Treatments (10 papers), Chronic Myeloid Leukemia Treatments (9 papers), Lymphoma Diagnosis and Treatment (8 papers), Acute Myeloid Leukemia Research (7 papers), Acute Lymphoblastic Leukemia research (6 papers) and Polyomavirus and related diseases (5 papers). The work is most often cited by research in Hematology (1.1k citations), Genetics (394 citations), Immunology (416 citations), Oncology (477 citations) and Transplantation (43 citations). Edward Kanfer has collaborated with scholars based in United Kingdom, Italy and France. Frequent co-authors include Jane F. Apperley, Richard Szydlo, Eduardo Olavarría, John M. Goldman, Amin Rahemtulla, D Samson, Francesco Dazzi, Chrissy Giles, S Armitage and Roseanna Hargreaves. Their work appears in journals such as Blood, Bone Marrow Transplantation, British Journal of Haematology, British Journal of Cancer and Leukemia.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact